Chargement en cours...
Identifying Key Benefits in European Off-Patent Biologics and Biosimilar Markets: It is Not Only About Price!
Biosimilar medicines have shown similarity with the originator biologic and offer a similar clinical outcome generally at a lower cost. This paper identifies benefits of off-patent biologics and biosimilars, and illustrates these benefits with empirical data from Europe. We provide a narrative revie...
Enregistré dans:
| Publié dans: | BioDrugs |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Springer International Publishing
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7113204/ https://ncbi.nlm.nih.gov/pubmed/31792843 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40259-019-00395-w |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|